[
  {
    "date": "2023-12-30",
    "symbol": "NLSPW",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 897680,
    "prepaidexpenseandotherassetscurrent": 925382,
    "assetscurrent": 1823062,
    "propertyplantandequipmentnet": 6694,
    "otherassetsnoncurrent": 16885,
    "assets": 1846641,
    "accountspayablecurrent": 265864,
    "shorttermnonbankloansandnotespayable": 1633746,
    "accruedliabilitiescurrent": 1652270,
    "liabilitiescurrent": 7919550,
    "deferredrevenuenoncurrent": 2499969,
    "pensionandotherpostretirementdefinedbenefitplansliabilitiesnoncurrent": 260685,
    "liabilities": 10680204,
    "commonstockvalue": 733413,
    "treasurystockvalue": 64858,
    "additionalpaidincapital": 61029437,
    "retainedearningsaccumulateddeficit": -70373484,
    "accumulatedothercomprehensiveincomelossnetoftax": -158071,
    "stockholdersequity": -8833563,
    "liabilitiesandstockholdersequity": 1846641,
    "othershorttermborrowings": 1633746,
    "commonstockparorstatedvaluepershare": 0.02,
    "commonstocksharesissued": 35671780,
    "commonstocksharesoutstanding": 35671780,
    "treasurysharesparvalue": 0.02,
    "treasurysharessharesissued": 3242887,
    "treasurysharessharesoutstanding": 3242887,
    "researchanddevelopmentexpense": 5908288,
    "generalandadministrativeexpense": 5898775,
    "operatingexpenses": 11807063,
    "operatingincomeloss": -11807063,
    "othernonoperatingincomeexpense": -219812,
    "interestexpense": 119920,
    "interestexpenserelatedparty1": 25233,
    "netincomeloss": -12172029,
    "othercomprehensiveincomelosspensionandotherpostretirementbenefitplansadjustmentnetoftax": 107280,
    "comprehensiveincomenetoftax": -12279309,
    "earningspersharebasic": -0.32,
    "weightedaveragenumberofsharesoutstandingbasic": 38176020,
    "earningspersharediluted": -0.32,
    "weightedaveragenumberofdilutedsharesoutstanding": 38176020,
    "sharesoutstanding": 35671780,
    "stockissuedduringperiodvalueother": 64858,
    "stockholdersequityothershares": 3242887,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 164907,
    "pensionexpense": 59526,
    "depreciation": 11408,
    "allocatedsharebasedcompensationexpense": 164906,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 632125,
    "increasedecreaseinaccountspayable": 2260258,
    "increasedecreaseininterestpayablenet": 25605,
    "increasedecreaseinotheraccruedliabilities": 640228,
    "increasedecreaseinothernoncurrentliabilities": -42243,
    "netcashprovidedbyusedinoperatingactivities": -9684466,
    "proceedsfromnotespayable": 1633746,
    "netcashprovidedbyusedinfinancingactivities": 1633746,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -8050720,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 897680,
    "interestpaidnet": 145153,
    "scheduleofprojectedbenefitobligationandthechangestothefairvalueoftheplanassetsofthepensionplantabletextblock": "The reconciliation of the projected benefit obligationand the changes to the fair value of the plan assets of the pension plan are shown in the following table:",
    "scheduleofunrecognizedpensioncostinaccumulatedothercomprehensiveincomelosstabletextblock": "The following table shows the components of unrecognizedpension cost in accumulated other comprehensive income/loss that have not yet been recognized as components of net periodic pension cost:",
    "scheduleofweightedaverageofthekeyassumptionsusedtocomputethebenefitobligationstabletextblock": "The weighted average of the key assumptions usedto compute the benefit obligations were as follows:",
    "vendorprepayments": 821266,
    "prepaidtaxes": 24433,
    "otherreceivables": 10664,
    "prepaidinsurance": 69019,
    "propertyplantandequipmentgross": 13341,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 32866,
    "accruedprofessionalfeescurrent": 332690,
    "accruedmarketingcostscurrent": 112635,
    "shorttermbankloansandnotespayable": 25605,
    "accruedcommitmentfee": 184672,
    "accruedbonusescurrentandnoncurrent": 960025,
    "accruedliabilitiesandotherliabilities": 36643,
    "definedbenefitplanservicecost": 53920,
    "definedbenefitplaninterestcost": 14416,
    "definedbenefitplanexpectedreturnonplanassets": 14767,
    "othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditbeforetax": -3031,
    "definedbenefitplanothercosts": 2926,
    "definedbenefitplannetperiodicbenefitcost": 59525,
    "definedbenefitplanbenefitobligation": 809028,
    "definedbenefitplanfairvalueofplanassets": 548343,
    "definedbenefitplanotherchanges": 38654,
    "definedbenefitplanactuarialgainloss": -123388,
    "definedbenefitplanforeigncurrencyexchangeratechangesbenefitobligation": 6087,
    "definedbenefitplanactualreturnonplanassets": 27844,
    "definedbenefitplancontributionsbyemployer": 38737,
    "definedbenefitplanplanassetscontributionsbyplanparticipant": 20655,
    "definedbenefitplanassetstransferredtofromplan": 17999,
    "definedbenefitplanadministrationexpenses": 2926,
    "definedbenefitplanplanassetsforeigncurrencytranslationgainloss": -2581,
    "accumulatedothercomprehensiveincomelossdefinedbenefitpensionandotherpostretirementplansnetoftax": -158073,
    "othercomprehensiveincomedefinedbenefitplansnetunamortizedgainlossarisingduringperiodnetoftax": 110313,
    "othercomprehensiveincomelosspensionandotherpostretirementbenefitplansadjustmentbeforetax": 161104,
    "othercomprehensiveincomelossamortizationadjustmentfromaocipensionandotherpostretirementbenefitplansfornetpriorservicecostcreditnetoftax": 3031,
    "othercomprehensiveincomedefinedbenefitplansadjustmentnetoftaxportionattributabletoparent": -3031,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationdiscountrate": 0.0145,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationrateofcompensationincrease": 0.0065,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationweightedaverageinterestcreditingrate": 0.0145,
    "definedbenefitplanassumptionsusedcalculatingbenefitobligationexpectedlongtermreturnonassets": 0.023,
    "definedbenefitplanassumptionsusedcalculatingnetperiodicbenefitcostinflationrate": 0.0125,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 19045043,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 307844,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1863658,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 776344,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 245809,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 0.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 449515,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1414143,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1414146,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 0.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 399515,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 0.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 245809,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 0.27,
    "deferredtaxassetsoperatinglosscarryforwards": 4337728,
    "deferredtaxassetsdeferredincome": 264997,
    "deferredtaxassetsvaluationallowance": 4602725,
    "deferredincometaxexpensebenefit": 852486,
    "othertaxexpensebenefit": 852486,
    "incometaxexpensebenefitcontinuingoperationsadjustmentofdeferredtaxassetliability": -852486,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.106,
    "effectiveincometaxratereconciliationotheradjustments": -0.036,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.07,
    "classofwarrantorrightreasonforissuingtononemployees": "Eachunit consisted of one common share and one warrant to purchase one common share (the “Warrants”).",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.497,
    "taxbenefitsmorelikelytoberecognizedpercentage": 0.5,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5747127,
    "debtinstrumentinterestratestatedpercentage": 0.1,
    "debtinstrumentunamortizeddiscount": 67008,
    "debtinstrumentconvertibletermsofconversionfeature": "the notes were able to be voluntarily convertedinto common shares of the Company prior to the maturity date at a 20% discount (i) to any subsequent qualified equity financing roundof at least $6 million in the aggregate or (ii) upon a change of control.",
    "debtunregisteredwarrantallocation": "the noteholders received unregistered warrants to purchase common shares of the Company equalto an aggregate of 10% of the note amount of each noteholder, divided by $0.4970",
    "nonrefundableupfrontpayment": 2500000,
    "receivenonrefundablemilestonepayments": 16000000,
    "estimatedtotaltransactionprice": 2500000,
    "deferredrevenuerevenuerecognized1": 2500000,
    "deferredrevenue": 2500000,
    "definedbenefitplannetperiodicbenefitcostcreditexcludingservicecoststatementofincomeorcomprehensiveincomeextensiblelist": "http://fasb.org/us-gaap/2023#PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
    "projectedbenefitobligationspercentagerate": 0.1,
    "licenseconsideration": 250000,
    "milestonepaymentsduedescription": "(i) $750,000 payable following the end of a Phase II meeting with the FDA, with the amount tobe reduced to $375,000 if toxicology studies must be repeated; (ii) $2 million following the earlier of U.S. Food and Drug Administration(“FDA”) marketing authorization of Quilience or Nolazol; (iii) 1% of any upfront and milestone payments, if any, fromany sublicensees and (iv) $3 million as a one-time payment upon the Company’s product candidate reaching $250 million in cumulativesales.",
    "paymentsofstockissuancecosts": 700000,
    "aggregategrossproceedspercentage": 0.05,
    "unitofferingmaximum": 20000000,
    "numberofcommonsharespercentage": 1.5,
    "unitpriceperunit": 1.5,
    "exercisepricepershare": 2.03,
    "cashplacement": 140000,
    "commissionratepercentage": 0.03,
    "commonsharewarrants": 3304492,
    "treasurystockcommonshares": 3242887,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y9M18D",
    "shareprice": 0.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 54899,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 471347,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y9M14D",
    "operatinglosscarryforwards": 40900000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 15500000,
    "relatedpartytransactionamountsoftransaction": 121658,
    "deconsolidationrelatedpartydescription": "the Company has agreed to pay CHG BioVenture SA a monthly fee CHF 4’375 ($4,733) plus 7.7% VAT for his services.In addition, CHG BioVenture SA is eligible for a 1% success fee payment in the event of closing of a partnering agreement in China.",
    "addendumstoshorttermloanagreements": "the Company entered into twoaddendums to the Short Term Loan Agreements with Ronald Hafner, the Company’s Chairman of the Board of Directors. These addendumsextend the maturity date under the Loan Agreements to June 30, 2025, for the aggregate amount of CHF 750,000.",
    "entityregistrantname": "NLS PHARMACEUTICS LTD.",
    "tradingsymbol": "NLSP",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 35671780,
    "amendmentflag": "false",
    "entitycentralindexkey": 1783036,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39957",
    "entityincorporationstatecountrycode": "V8",
    "entityaddressaddressline1": "The Circle 6",
    "entityaddresspostalzipcode": 8058,
    "entityaddresscityortown": "Zurich",
    "entityaddresscountry": "CH",
    "contactpersonnelname": "Alexander Zwyer",
    "cityareacode": 41,
    "localphonenumber": "44 512 21 50",
    "contactpersonnelemailaddress": "@nls-pharma.com",
    "entityaddressaddressline2": "Postfach",
    "security12btitle": "Common shares, nominal value CHF 0.02 per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1358,
    "auditorname": "PricewaterhouseCoopers AG",
    "auditorlocation": "Zurich, Switzerland"
  }
]